THE Pharmacy Guild is calling for
a 12 month deferral of the final
decision on the rescheduling of
OTC codeine products, in order to
allow time for a national realtime
monitoring system to be
implemented.
“It is a matter of public health
that these products remain
available in Schedule 3 to treat mild
to moderate pain when it occurs,”
the Guild wrote in its Forerfront
fortnightly update yesterday.
“Existing scheduling of these
products allows timely access to
important analgesic medicines in
a pharmacy environment where
an appropriate level of supervision
exists,” the Guild said.
Recording of codeine sales needs
to be supported by nationally
consistent provisions in each
jurisdiction to mandate real-time
recording of codeine sales, said
executive director David Quilty.
He also urged the introduction
of mandatory labels to advise
consumers of the potential for
dependence from prolonged use.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Oct 15
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.